Here, we found that disrupting autophagic flux had a substantial anticancer effect on RCC cells treated with the PDPK1 inhibitor GSK470, suggesting that autophagy may have a protective effect that is activated when the PDPK1-Akt-mTOR signaling pathway is blocked. This evidence concerns the gene AKT1 and renal cell carcinoma.